Edward Murphy, MD, MPH

Displaying 101 - 125 of 169

  1. Swindells S, Komarow L, Tripathy S, Cain KP, MacGregor RR, Achkar JM, Gupta A, Veloso VG, Asmelash A, Omoz-Oarhe AE, Gengiah S, Lalloo U, Allen R, Shiboski C, Andersen J, Qasba SS, Katzenstein DK, AIDS Clinical Trials Group 5253 Study Team . Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253. Int J Tuberc Lung Dis. 2013 Apr; 17(4):532-9.
    http://www.ncbi.nlm.nih.gov/pubmed/22014098
  2. de Almeida Neto C, Mendrone A, Custer B, Liu J, Carneiro-Proietti AB, Leão SA, Wright DJ, Murphy EL, Sabino EC. Interdonation intervals and patterns of return among blood donors in Brazil. Transfusion. 2012 Apr; 52(4):722-8.
    http://www.ncbi.nlm.nih.gov/pubmed/21981543
  3. Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev. 2012 Apr; 26(2):164-80.
    http://www.ncbi.nlm.nih.gov/pubmed/21872426
  4. Nébié K, Ouattara S, Sanou M, Kientega Y, Dahourou H, Ky L, Kienou K, Diallo S, Bigirimana F, Fretz C, Murphy EL, Lefrère JJ. Poor procedures and quality control among nonaffiliated blood centers in Burkina Faso: an argument for expanding the reach of the national blood transfusion center. Transfusion. 2011 Jul; 51(7 Pt 2):1613-8.
    http://www.ncbi.nlm.nih.gov/pubmed/21736582
  5. Kleinman SH, Triulzi DJ, Murphy EL, Carey PM, Gottschall JL, Roback JD, Carrick D, Mathew S, Wright DJ, Cable R, Ness P, Gajic O, Hubmayr RD, Looney MR, Kakaiya RM. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components. Transfusion. 2011 Oct; 51(10):2078-91.
    http://www.ncbi.nlm.nih.gov/pubmed/21446938
  6. Bahrami SH, Guiltinan AM, Schlumpf KS, Scott E, Banks LL, D'Andrea P, Hartman EL, Vij V, Wright DJ, Spencer B, Murphy EL. Donation frequency of blood donors participating in a prospective cohort study of iron status. Transfusion. 2011 Jun; 51(6):1207-12.
    http://www.ncbi.nlm.nih.gov/pubmed/21658037
  7. Tagny CT, Mbanya D, Leballais L, Murphy E, Lefrère JJ, Laperche S. Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon. Transfusion. 2011 Jan; 51(1):184-90.
    http://www.ncbi.nlm.nih.gov/pubmed/20663109
  8. Rios JA, Schlumpf KS, Kakaiya RM, Triulzi DJ, Roback JD, Kleinman SH, Murphy EL, Gottschall JL, Carey PM. Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion. 2011 Jun; 51(6):1197-206.
    http://www.ncbi.nlm.nih.gov/pubmed/21182532
  9. Lefrère JJ, Dahourouh H, Dokekias AE, Kouao MD, Diarra A, Diop S, Tapko JB, Murphy EL, Laperche S, Pillonel J. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion. 2011 Mar; 51(3):486-92.
    http://www.ncbi.nlm.nih.gov/pubmed/20880002
  10. Rice MS, Custer BS, Hindes DA, Hirschler NV, Nguyen KA, Busch MP, Murphy EL. Genetic research in the blood bank: acceptability to Northern California donors. Transfusion. 2010 Sep; 50(9):1951-8.
    http://www.ncbi.nlm.nih.gov/pubmed/20561291
  11. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Vij V, Simon TL. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011 Mar; 51(3):511-22.
    http://www.ncbi.nlm.nih.gov/pubmed/20804527
  12. Murphy EL, Fang J, Tu Y, Cable R, Hillyer CD, Sacher R, Triulzi D, Gottschall JL, Busch MP. Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis. 2010 Aug 15; 202(4):576-84.
    http://www.ncbi.nlm.nih.gov/pubmed/20617929
  13. Biswas HH, Kaidarova Z, Garratty G, Gibble JW, Newman BH, Smith JW, Ziman A, Fridey JL, Sacher RA, Murphy EL. Increased all-cause and cancer mortality in HTLV-II infection. J Acquir Immune Defic Syndr. 2010 Jul; 54(3):290-6.
    http://www.ncbi.nlm.nih.gov/pubmed/20512047
  14. Hahn JA, Evans JL, Davidson PJ, Lum PJ, Page K. Hepatitis C virus risk behaviors within the partnerships of young injecting drug users. Addiction. 2010 Jul; 105(7):1254-64.
    http://www.ncbi.nlm.nih.gov/pubmed/20336721
  15. Goncalez T, Sabino E, Sales N, Chen YH, Chamone D, Busch M, Murphy E, Custer B, McFarland W. Human immunodeficiency virus test-seeking blood donors in a large blood bank in São Paulo, Brazil. Transfusion. 2010 Aug; 50(8):1806-14.
    http://www.ncbi.nlm.nih.gov/pubmed/20456699
  16. Mast AE, Schlumpf KS, Wright DJ, Custer B, Spencer B, Murphy EL, Simon TL. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion. 2010 Aug; 50(8):1794-802.
    http://www.ncbi.nlm.nih.gov/pubmed/20412525
  17. Tobler LH, Bahrami SH, Kaidarova Z, Pitina L, Winkelman VK, Vanderpool SK, Guiltinan AM, Cooper S, Busch MP, Murphy EL. A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME). Transfusion. 2010 Jul; 50(7):1513-23.
    http://www.ncbi.nlm.nih.gov/pubmed/20345567
  18. Edgren G, Kamper-Jørgensen M, Eloranta S, Rostgaard K, Custer B, Ullum H, Murphy EL, Busch MP, Reilly M, Melbye M, Hjalgrim H, Nyrén O. Duration of red blood cell storage and survival of transfused patients (CME). Transfusion. 2010 Jun; 50(6):1185-95.
    http://www.ncbi.nlm.nih.gov/pubmed/20158690
  19. Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G. Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques. J Virol. 2010 Mar; 84(6):3043-58.
    http://www.ncbi.nlm.nih.gov/pubmed/20071587
  20. Carrick DM, Norris PJ, Endres RO, Pandey S, Kleinman SH, Wright D, Sun Y, Busch MP, National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II . Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion. 2011 Oct; 51(10):2092-101.
    http://www.ncbi.nlm.nih.gov/pubmed/20640055
  21. Carneiro-Proietti AB, Sabino EC, Sampaio D, Proietti FA, Gonçalez TT, Oliveira CD, Ferreira JE, Liu J, Custer B, Schreiber GB, Murphy EL, Busch MP. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion. 2010 Apr; 50(4):918-25.
    http://www.ncbi.nlm.nih.gov/pubmed/20003051
  22. Gonçalez TT, Sabino EC, Salles NA, de Almeida-Neto C, Mendrone A, Dorlhiac-Laccer PE, Liu J, Murphy EL, Schreiber GB. The impact of simple donor education on donor behavioral deferral and infectious disease rates in São Paulo, Brazil. Transfusion. 2010 04; 50(4):909-17.
    http://www.ncbi.nlm.nih.gov/pubmed/20003056
  23. Remesar MC, Gamba C, Colaianni IF, Puppo M, Sartor PA, Murphy EL, Neilands TB, Ridolfi MA, Leguizamón MS, Kuperman S, Del Pozo AE. Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina. Transfusion. 2009 Nov; 49(11):2352-8.
    http://www.ncbi.nlm.nih.gov/pubmed/19903291
  24. Shiboski CH, Webster-Cyriaque JY, Ghannoum M, Greenspan JS, Dittmer D, Oral HIV/AIDS Research Alliance, Subcommittee of the AIDS Clinical Trial Group . Overview of the oral HIV/AIDS Research Alliance Program. Adv Dent Res. 2011 Apr; 23(1):28-33.
    http://www.ncbi.nlm.nih.gov/pubmed/19389036
  25. Murphy EL, McFarland W, Lefrère JJ. Teaching transfusion medicine research methods in the developing world. Transfusion. 2009 Aug; 49(8):1532-4.
    http://www.ncbi.nlm.nih.gov/pubmed/19732403